Evaluating the clinical efficacy of neoadjuvant chemotherapy for node-positive upper tract urothelial carcinoma: A multi-center cohort study
Main Authors: | K. Shigeta, K. Matsumoto, N. Tanaka, T. Murakami, T. Anno, K. Umeda, M. Izawa, T. Sanjo, Y. Yasumizu, T. Takeda, S. Morita, T. Kosaka, R. Mizuno, H. Asanuma, M. Oya |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320327683 |
Similar Items
-
Predicting the risk factors for muscle-invasive intravesical tumors that subsequently progressed from upper-tract urothelial carcinoma: Results of a multi-center cohort study
by: K. Shigeta, et al.
Published: (2020-07-01) -
Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma
by: Kikuchi, E., et al.
Published: (2022) -
Comparing the oncological outcomes between pure laparoscopic radical nephroureterectomy and laparoscopic assisted nephroureterectomy for upper-tract urothelial carcinoma: A multi-center cohort study adjusted by propensity score matching
by: K. Shigeta, et al.
Published: (2020-07-01) -
Trends in the utilizaton of platinum-based neoadjuvant chemotherapy for upper tract urothelial carcinoma
by: H. Horiguchi, et al.
Published: (2020-07-01) -
Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer
by: David D’Andrea, et al.
Published: (2020-07-01)